Pharmaceutical production of anti-tumor and immune-potentiating Enterococcus faecalis-2001 β-glucans: enhanced activity of macrophage and lymphocytes in tumor-implanted mice.
Current Pharmaceutical Biotechnology, October 2017
Gu, Yeun-Hwa, Choi, Hyunju, Yamashita, Takenori, Kang, Ki-Mun, Iwasa, Masahiro, Lee, Moon-Jo, Lee, Kyoung Hae, Kim, Cheorl-Ho, Yeun-Hwa Gu, Hyunju Choi, Takenori Yamashita, Ki-Mun Kang, Masahiro Iwasa, Moon-Jo Lee, Kyoung Hae Lee, Cheorl-Ho Kim
Enterococcus faecalis 2001 is a probiotic lactic acid bacterium and has been used as a biological response modifier (BRM). From physiological limitation of bacterial preservation in storage and safety, the live E. faecalis 2001 has been heat-treated and the BRM components containing high level of β-glucan, named EF-2001, has been prepared. The heat-treated EF-2001 has been examined for the antioxidative potential for radical scavenging and anti-tumor activities as well as immune-enhancing response in mice. The lymphocyte versus polymorphonuclear leukocyte ratios was increased in mice upon treatment with EF-2001. The number of lymphocytes was increased in the EF-2001-treated group. In the mice bearing two different Ehrlich solid and Sarcoma-180 carcinomas, the treatment with EF-2001 resulted in anti-tumor action. Tumor-suppressive capacity upon treatment with EF-2001 was significantly increased compared to normal controls. During the time interval administration of 5 weeks between priming and secondary administration of EF-2001, the expression and production levels of TNF- were also observed in the EF-2001-administered mice. Additionally, anti-tumor activity examined with the intravenous administration of EF 2001 with a 34 time intervals was also observed, as the growth of Sarcoma180 cells was clearly inhibited by the EF-2001. From the results, it was suggested that the immune response is enhanced from the anti-oxidative provoked by the EF-2001 and anti-tumor activity is provoked through NK cells and TNF -.
|Members of the public||2||100%|
|Readers by professional status||Count||As %|
|Student > Doctoral Student||1||33%|
|Student > Master||1||33%|
|Readers by discipline||Count||As %|
|Biochemistry, Genetics and Molecular Biology||2||67%|
|Pharmacology, Toxicology and Pharmaceutical Science||1||33%|
|Agricultural and Biological Sciences||1||33%|
|Medicine and Dentistry||1||33%|